Veterinary Cardiology Market Size & Growth Forecast 2026–2035, By Segments (Animal Type, Indication, End Use, Product, Distribution Channel), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Veterinary Cardiology Market size was worth USD 2.95 Billion in 2025 and is poised to grow at a 8.4% CAGR between 2026 and 2035, attaining USD 6.61 Billion by 2035. The industry revenue for 2026 is assessed at USD 3.17 billion.
Get more details on this report
Request Free Sample ReportVeterinary Cardiology Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 40.79% share in 2025, supported by advanced companion animal care, specialized veterinary services, referral-based care, and higher spending on pet health.
- Asia Pacific is projected to grow at a 9.49% CAGR as veterinary care access expands, specialty services improve, and pet owners increasingly seek advanced cardiac diagnosis and treatment.
Segment Momentum
- Companion animals lead with 65.26% share due to higher screening rates, routine follow-ups, and stronger owner willingness to pursue specialized cardiac diagnostics and long-term treatment in dogs and cats.
- Production animals are expanding fastest as livestock operators increasingly link cardiovascular health with productivity and breeding value, increasing demand for diagnostic evaluation from a relatively underpenetrated base.
Market Expansion Drivers
- Rising prevalence of canine heart diseases increasing demand for advanced veterinary cardiology diagnostics.
- Growing pet healthcare expenditure supporting adoption of specialized cardiac therapeutics and monitoring solutions.
- Expanding veterinary awareness programs accelerating early diagnosis and preventive cardiac care adoption.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Prominent companies in the veterinary cardiology market include Boehringer Ingelheim International GmbH (Germany), Ceva Santé Animale (France), IDEXX Laboratories, Inc. (United States), Esaote S.p.A. (Italy), Sound Technologies Inc. (United States), Vmed Technology (United States), Zoetis Inc. (United States), Merck & Co., Inc. [Merck Animal Health] (United States), FUJIFILM Holdings Corporation (Japan).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As degenerative valve disease, cardiomyopathy, and age-related cardiac complications are identified more frequently in companion dogs, veterinarians are relying more heavily on imaging and monitoring tools that can distinguish benign murmurs from progressive heart dysfunction. This is pushing the veterinary cardiology market toward greater use of echocardiography, ECG systems, Holter monitoring, and blood pressure assessment as clinics seek earlier and more accurate evaluation before treatment decisions are made. The effect is especially visible in referral networks and multi-specialty practices, where rising caseloads are driving demand for higher-capability diagnostic platforms and strengthening service volumes tied to cardiac workups.
Growing pet healthcare expenditure supporting adoption of specialized cardiac therapeutics and monitoring solutions
Higher willingness among pet owners to spend on advanced care is changing how chronic heart conditions are managed, particularly for dogs requiring long-term medication, repeat evaluations, and ongoing monitoring. In the veterinary cardiology market, this supports broader uptake of specialized therapeutics, follow-up diagnostics, wearable or ambulatory monitoring tools, and treatment plans that would previously have been deferred or limited to severe cases. As owners increasingly approach cardiac disease management with the same continuity mindset applied to other chronic companion animal conditions, clinics and specialty providers are expanding cardiology offerings, reinforcing demand for premium cardiac care pathways.
Expanding veterinary awareness programs accelerating early diagnosis and preventive cardiac care adoption
Professional education initiatives, continuing training, and awareness campaigns are improving how general practitioners recognize subtle cardiac signs and when they refer patients for specialist evaluation. This is influencing the veterinary cardiology market by moving case identification earlier in the disease pathway, when murmurs, arrhythmias, or breed-linked risks can be investigated before overt heart failure develops. In practice, stronger clinical awareness increases screening during routine visits, supports preventive monitoring for at-risk animals, and creates steadier demand for cardiology consultations and diagnostic services rather than concentrating utilization only in late-stage emergency presentations.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of canine heart diseases increasing demand for advanced veterinary cardiology diagnostics | 2.00% | Moderate | North America, Asia Pacific, Europe | High | Near Term |
| Growing pet healthcare expenditure supporting adoption of specialized cardiac therapeutics and monitoring solutions | 1.70% | Moderate | North America, Europe | High | Mid Term |
| Expanding veterinary awareness programs accelerating early diagnosis and preventive cardiac care adoption | 1.40% | Moderate | Asia Pacific, North America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held a 40.79% share of the veterinary cardiology market in 2025, backed by a well-established companion animal care ecosystem and broader access to specialized veterinary services. The region’s leadership is strengthened by higher utilization of advanced cardiac diagnostics, referral-based care pathways, and stronger spending on pet health, which together sustain demand for cardiology consultations, monitoring, and treatment in everyday clinical practice. A more mature base of specialty hospitals and trained veterinary professionals also helps convert cardiac case identification into procedure volume and follow-on care.
Asia Pacific is projected to expand at a 9.49% CAGR over the forecast period, with growth in the veterinary cardiology market being impelled by rising access to veterinary care and increasing adoption of specialized animal health services. As clinical capabilities improve across urban centers and pet owners become more willing to pursue diagnosis and treatment for complex conditions, demand is shifting beyond basic care toward cardiology-focused evaluation and management. This is creating stronger momentum for advanced diagnostics and specialty case handling across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Specialty Diagnostic ServicesGermany strengthens the veterinary cardiology market through widespread use of advanced diagnostic imaging and referral-based specialty services. Veterinary professionals in Germany increasingly emphasize early detection and structured management of cardiac conditions in companion animals.
France 🇫🇷
Referral Care DevelopmentFrance focuses on strengthening veterinary cardiology through referral networks and specialized clinical expertise for complex cardiovascular cases. Veterinary practices in France continue adopting advanced diagnostic tools that support accurate assessment and ongoing treatment planning.
Italy 🇮🇹
Specialized Veterinary PracticeItaly advances the veterinary cardiology market by expanding access to specialized cardiac care within companion animal practices. Italian veterinary professionals increasingly utilize echocardiography and other diagnostic technologies to support timely cardiovascular disease management.
Japan 🇯🇵
Preventive Cardiac ManagementJapan prioritizes preventive veterinary cardiology supported by routine health assessments and growing awareness of age-related heart disease in pets. Veterinary clinics in Japan continue incorporating specialized cardiac diagnostics into comprehensive animal healthcare services.
South Korea 🇰🇷
Advanced Companion HealthcareSouth Korea expands veterinary cardiology capabilities through investment in specialized pet healthcare services and modern diagnostic equipment. Veterinary providers in South Korea increasingly offer comprehensive cardiac evaluations as companion animal ownership continues evolving.
United States 🇺🇸
Companion Care ExpansionThe U.S. veterinary cardiology market is supported by increasing demand for advanced cardiac diagnostics and specialist care for companion animals. Veterinary hospitals across the U.S. continue expanding access to imaging technologies and long-term cardiovascular disease management.
Segment Leadership and Growth Trends
Veterinary Cardiology Market Share (%), Animal Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportCompanion Animals held the leading position in the veterinary cardiology market in 2025, accounting for a 65.26% share. This leadership is underpinned by the higher frequency of cardiac screening, diagnosis, and follow-up care in dogs and cats, where owners are more likely to pursue specialized cardiology consultations and long-term treatment. The veterinary cardiology market continues to see stronger utilization in companion animals because these cases are more consistently brought into clinical settings, allowing earlier detection and more regular disease management than in other animal categories.
Production Animals are emerging as the fastest-growing segment in the veterinary cardiology market as livestock care becomes more attentive to health conditions that affect productivity, breeding value, and overall herd performance. Growth is being underpinned by increasing recognition that cardiovascular issues can carry direct economic consequences in managed animal populations, which is driving greater diagnostic attention relative to traditional care patterns. Compared with companion animals, this segment is gaining momentum from a lower established base, creating clearer room for expanded adoption of cardiology evaluation in production-focused veterinary practice.
Indication Segment Analysis: Congestive Heart Failure (Largest Segment) vs Arrhythmias (Fastest-Growing Segment)
In 2025, Congestive Heart Failure represented the largest indication in the veterinary cardiology market, with a 40.21% share. Its leading position is underpinned by the fact that heart failure cases often require ongoing clinical management, repeat assessments, and sustained therapeutic intervention once diagnosed. Within the veterinary cardiology market, this creates a steady concentration of case volume around congestive heart failure, as it is a condition that typically moves beyond one-time evaluation and into continued monitoring and treatment.
Arrhythmias are the fastest-growing indication in the veterinary cardiology market due to rising attention to rhythm abnormalities that require more precise cardiac assessment and earlier identification in clinical practice. This segment is gaining momentum as veterinary providers place greater emphasis on detecting conditions that may not be evident through routine examination alone, increasing the role of cardiology-specific evaluation. Relative to more established indications, arrhythmias are benefiting from expanding diagnostic focus, which is accelerating their growth within specialized veterinary cardiac care.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Animal Type | Companion Animals, Production Animals | Companion Animals | Production Animals |
| Indication | Congestive Heart Failure, Myocardial (Heart Muscle) Disease, Arrhythmias, Others | Congestive Heart Failure | Arrhythmias |
| End Use | Veterinary Hospitals & Clinics, Others | Veterinary Hospitals & Clinics | Veterinary Hospitals & Clinics |
| Product | Pharmaceuticals, Diagnostics | Pharmaceuticals | Diagnostics |
| Distribution Channel | Hospital/Clinic Pharmacy, Retail, E-Commerce | Hospital/Clinic Pharmacy | E-Commerce |
Competitive Landscape and Market Positioning
1. Boehringer Ingelheim International GmbH (Germany)
2. Ceva Santé Animale (France)
3. IDEXX Laboratories Inc. (United States)
4. Esaote S.p.A. (Italy)
5. Sound Technologies Inc. (United States)
6. Vmed Technology (United States)
7. Zoetis Inc. (United States)
8. Merck & Co. Inc. [Merck Animal Health] (United States)
9. FUJIFILM Holdings Corporation (Japan)
The veterinary cardiology market is evolving through the adoption of advanced diagnostic imaging systems and enhanced monitoring technologies designed to improve cardiac care in animals. Industry participants are increasingly introducing sophisticated solutions that support early disease detection and treatment planning, while innovation in portable and minimally invasive devices is expanding accessibility for veterinary practitioners. Rising pet healthcare expenditure is also reinforcing demand for specialized cardiology services and equipment.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Boehringer Ingelheim & Eko Health | Apr-26 | Boehringer Ingelheim and Eko Health launched Eko Vet+ featuring CANINEBEAT AI, an integrated diagnostic solution for the detection and grading of canine heart murmurs. By combining digital stethoscope technology with AI-driven analysis, the platform enhances diagnostic accuracy and early detection of structural heart disease in clinical veterinary settings. |
| Fujifilm | Mar-25 | Fujifilm integrated AI-automated echocardiography analysis into its LISENDO 880 ultrasound system through a partnership with Us2.ai. This technology automates complex cardiac measurements, reducing inter-observer variability and increasing diagnostic efficiency for veterinary cardiologists, thereby streamlining the assessment of cardiac structure and function in animal patients. |
| Boehringer Ingelheim | Nov-24 | Boehringer Ingelheim launched the VETMEDIN oral solution, the first FDA-approved liquid formulation for managing congestive heart failure in dogs. This innovation provides a precise, convenient alternative to traditional tablet dosing, improving compliance and therapeutic outcomes for canine patients with myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). |
| Cronus Pharma Specialties | Apr-24 | Cronus Pharma Specialties received FDA approval for the first generic Pimomedin (pimobendan) chewable tablets. This launch increases the availability of cost-effective, clinically equivalent treatment options for canine congestive heart failure, supporting broader access to standard-of-care pharmacotherapy within the veterinary cardiology market. |
| Chulalongkorn University | Jan-24 | A veterinary surgical team at Chulalongkorn University performed Thailand's first minimally invasive mitral valve repair (MVR) on a dog using a mitral clamp. This procedure eliminates the need for cardiopulmonary bypass (artificial heart/lung machine), significantly reducing surgical trauma and recovery time, and demonstrating the advancement of interventional cardiology techniques in small animal practice. |
| Invoxia | Jan-23 | Invoxia launched a smart dog collar equipped with integrated AI and biometric sensors designed to track respiratory and cardiac vitals. Developed in collaboration with veterinary specialists, the device provides continuous health monitoring and early anomaly detection, enabling proactive intervention and longitudinal data tracking for improved preventive cardiac care in domestic canine populations. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Veterinary Cardiology Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Veterinary Cardiology Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of veterinary cardiology?
What are the growth projections for the veterinary cardiology industry?
How is rising incidence of canine cardiac conditions influencing diagnostic adoption in the veterinary cardiology market?
How are awareness initiatives shaping diagnostic timing and care pathways in veterinary cardiology?
Why do companion animals dominate the veterinary cardiology market?
What is driving faster growth in production animals?
Why does North America lead the veterinary cardiology market?
How is Asia Pacific driving growth in the veterinary cardiology market?
Which companies dominate the veterinary cardiology landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization